Selective EGF-Receptor Inhibition in CD4 + T Cells Induces Anergy and Limits Atherosclerosis

Several epidermal growth factor receptor (EGFR) inhibitors have been successfully developed for the treatment of cancer, limiting tumor growth and metastasis. EGFR is also expressed by leukocytes, but little is known about its role in the modulation of the immune response. The aim of this study was...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of the American College of Cardiology Ročník 71; číslo 2; s. 160
Hlavní autori:	Zeboudj, Lynda, Maître, Mikael, Guyonnet, Lea, Laurans, Ludivine, Joffre, Jeremie, Lemarie, Jeremie, Bourcier, Simon, Nour-Eldine, Wared, Guérin, Coralie, Friard, Jonas, Wakkach, Abdelilah, Fabre, Elizabeth, Tedgui, Alain, Mallat, Ziad, Tharaux, Pierre-Louis, Ait-Oufella, Hafid
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 16.01.2018
Predmet:	Animals Antineoplastic Agents - pharmacology Atherosclerosis - immunology CD4-Positive T-Lymphocytes - immunology Cytokines - analysis Cytokines - classification Cytokines - immunology ErbB Receptors - antagonists & inhibitors Erlotinib Hydrochloride - pharmacology Immunity, Cellular - drug effects Immunity, Cellular - immunology Mice Plaque, Atherosclerotic - drug therapy Plaque, Atherosclerotic - immunology Plaque, Atherosclerotic - pathology Protein Kinase Inhibitors - pharmacology T-Lymphocytes, Regulatory - immunology atherosclerosis immunity inflammation lymphocyte
ISSN:	1558-3597, 1558-3597
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!